ALT: Leerink Initiates
Leerink Partners initiates coverage on Altimmune with an Outperform rating and a price target of $10
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.